Cargando…

Harnessing the integrated stress response for the treatment of multiple sclerosis

Multiple sclerosis (MS) is a chronic demyelinating autoimmune disease of the central nervous system (CNS) with no known cure. Though a dozen immunomodulatory therapies exist, their impact on progression of disease appears limited. The field has hence focused on alternate strategies for treatment suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Way, Sharon W., Popko, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792730/
https://www.ncbi.nlm.nih.gov/pubmed/26873788
http://dx.doi.org/10.1016/S1474-4422(15)00381-6
_version_ 1782421282500902912
author Way, Sharon W.
Popko, Brian
author_facet Way, Sharon W.
Popko, Brian
author_sort Way, Sharon W.
collection PubMed
description Multiple sclerosis (MS) is a chronic demyelinating autoimmune disease of the central nervous system (CNS) with no known cure. Though a dozen immunomodulatory therapies exist, their impact on progression of disease appears limited. The field has hence focused on alternate strategies for treatment such as enhancing remyelination and CNS repair. Recent progress has been made on a third complimentary treatment approach that involves protecting oligodendrocytes, and the myelin they generate and maintain, from inflammatory-mediated death via enhancement of the integrated stress response (ISR). Studies in cells and mouse models of MS have demonstrated that the ISR, an innate protective pathway that maintains proteostasis, may be effectively harnessed to aid in the protection of oligodendrocytes and myelin during inflammation. With one ISR-modifying drug already in clinical trial and a number of potential future therapies under investigation, this approach may offer an important component in halting the progression of multiple sclerosis.
format Online
Article
Text
id pubmed-4792730
institution National Center for Biotechnology Information
language English
publishDate 2016
record_format MEDLINE/PubMed
spelling pubmed-47927302017-04-01 Harnessing the integrated stress response for the treatment of multiple sclerosis Way, Sharon W. Popko, Brian Lancet Neurol Article Multiple sclerosis (MS) is a chronic demyelinating autoimmune disease of the central nervous system (CNS) with no known cure. Though a dozen immunomodulatory therapies exist, their impact on progression of disease appears limited. The field has hence focused on alternate strategies for treatment such as enhancing remyelination and CNS repair. Recent progress has been made on a third complimentary treatment approach that involves protecting oligodendrocytes, and the myelin they generate and maintain, from inflammatory-mediated death via enhancement of the integrated stress response (ISR). Studies in cells and mouse models of MS have demonstrated that the ISR, an innate protective pathway that maintains proteostasis, may be effectively harnessed to aid in the protection of oligodendrocytes and myelin during inflammation. With one ISR-modifying drug already in clinical trial and a number of potential future therapies under investigation, this approach may offer an important component in halting the progression of multiple sclerosis. 2016-02-10 2016-04 /pmc/articles/PMC4792730/ /pubmed/26873788 http://dx.doi.org/10.1016/S1474-4422(15)00381-6 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This manuscript version is made available under the CC BY-NC-ND 4.0 license.
spellingShingle Article
Way, Sharon W.
Popko, Brian
Harnessing the integrated stress response for the treatment of multiple sclerosis
title Harnessing the integrated stress response for the treatment of multiple sclerosis
title_full Harnessing the integrated stress response for the treatment of multiple sclerosis
title_fullStr Harnessing the integrated stress response for the treatment of multiple sclerosis
title_full_unstemmed Harnessing the integrated stress response for the treatment of multiple sclerosis
title_short Harnessing the integrated stress response for the treatment of multiple sclerosis
title_sort harnessing the integrated stress response for the treatment of multiple sclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792730/
https://www.ncbi.nlm.nih.gov/pubmed/26873788
http://dx.doi.org/10.1016/S1474-4422(15)00381-6
work_keys_str_mv AT waysharonw harnessingtheintegratedstressresponseforthetreatmentofmultiplesclerosis
AT popkobrian harnessingtheintegratedstressresponseforthetreatmentofmultiplesclerosis